Projected Income Statement: ASROCK Incorporation

Forecast Balance Sheet: ASROCK Incorporation

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026 2027
Net Debt 1 -3,387 -3,399 -3,302 -3,046 -3,220 -1,729 -90 -1,332
Change - -0.35% 2.85% 7.75% -5.71% 46.3% 94.79% -1,380%
Announcement Date 24/02/21 23/02/22 09/03/23 06/03/24 13/03/25 - - -
1TWD in Million
Estimates

Cash Flow Forecast: ASROCK Incorporation

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026 2027
CAPEX 1 34.88 46.39 87.77 16.4 1,197 50.5 51.5 485.7
Change - 32.99% 89.19% -81.32% 7,203.37% -95.78% 1.98% 843.04%
Free Cash Flow (FCF) 1 1,317 977.9 1,053 2,620 -275 -4,477 -1,968 2,554
Change - -25.76% 7.69% 148.79% -110.49% -1,528.25% 56.04% 229.78%
Announcement Date 24/02/21 23/02/22 09/03/23 06/03/24 13/03/25 - - -
1TWD in Million
Estimates

Forecast Financial Ratios: ASROCK Incorporation

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026 2027

Profitability

        
EBITDA Margin (%) 10.81% 15.94% 7.71% 7.05% 7.28% 5.72% 6.24% 6.39%
EBIT Margin (%) 10.37% 15.47% 6.92% 6.04% 6.52% 5.74% 6.06% 6.21%
EBT Margin (%) 10.36% 15.48% 8.36% 6.41% 7.55% 6.03% 6.34% 6.46%
Net margin (%) 7.61% 12.05% 6.23% 4.84% 5.02% 3.95% 3.91% 3.98%
FCF margin (%) 7.35% 4.95% 6.15% 13.79% -1.07% -9.28% -2.85% 3.09%
FCF / Net Income (%) 96.63% 41.07% 98.76% 285.07% -21.33% -235.14% -72.87% 77.53%

Profitability

        
ROA 12.4% 17.25% 6.95% 6.31% 7.58% 9.05% 9.85% 10.24%
ROE 20.81% 31.39% 12.95% 11.27% 14.79% 18.7% 22.22% 23.6%

Financial Health

        
Leverage (Debt/EBITDA) - - - - - - - -
Debt / Free cash flow - - - - - - - -

Capital Intensity

        
CAPEX / Current Assets (%) 0.19% 0.23% 0.51% 0.09% 4.67% 0.1% 0.07% 0.59%
CAPEX / EBITDA (%) 1.8% 1.47% 6.65% 1.22% 64.14% 1.83% 1.2% 9.18%
CAPEX / FCF (%) 2.65% 4.74% 8.33% 0.63% -435.48% -1.13% -2.62% 19.02%

Items per share

        
Cash flow per share 1 - 8.403 9.251 21.57 7.511 15.61 -3.44 9.99
Change - - 10.09% 133.15% -65.18% 107.83% -122.04% 390.41%
Dividend per Share 1 8 13 - 6.9 5.3 8.555 11.93 14.22
Change - 62.5% - - -23.19% 61.42% 39.45% 19.24%
Book Value Per Share 1 - 67.29 67.15 66.78 75.25 84.78 96.08 109
Change - - -0.2% -0.56% 12.7% 12.65% 13.34% 13.49%
EPS 1 11.22 19.53 8.65 7.54 10.54 15.41 21.86 26.66
Change - 74.06% -55.71% -12.83% 39.79% 46.2% 41.88% 21.95%
Nbr of stocks (in thousands) 120,642 122,925 121,993 121,641 123,254 123,548 123,548 123,548
Announcement Date 24/02/21 23/02/22 09/03/23 06/03/24 13/03/25 - - -
1TWD
Estimates
2025 *2026 *
P/E ratio 14.8x 10.4x
PBR 2.68x 2.37x
EV / Sales 0.55x 0.41x
Yield 3.76% 5.24%
More valuation ratios * Estimated data

EPS & Dividend

Y-o-Y evolution of P/E

Year-on-year evolution of the Yield

Trader
Investor
Global
Quality
ESG MSCI
B
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
227.50TWD
Average target price
327.50TWD
Spread / Average Target
+43.96%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. 3515 Stock
  4. Financials ASROCK Incorporation